Latest Biotech News

Contineum Therapeutics reported topline results from its Phase II VISTA trial of PIPE‑307, an M1 receptor antagonist developed with Janssen, and the study failed to meet its primary and secondary...

Hepta released proof‑of‑concept data indicating cell‑free DNA methylation signatures in plasma reflect liver biology, including fibrosis and cell‑type composition, based on an atlas assembled with...

Tel Aviv‑based Cassidy Bio closed an $8 million seed round led by Ahren Innovation Capital to develop an AI platform that predicts optimal combinations of guide RNAs, editing enzymes and delivery...

Aspen Neuroscience secured $115 million in Series C financing to support its autologous cell therapy program for Parkinson’s disease, expand manufacturing capacity and progress an ongoing clinical...

Abbott announced a definitive agreement to acquire Exact Sciences for $105 per share, a transaction valued at roughly $21 billion in equity and about $23 billion on an enterprise basis in some...

The U.S. Food and Drug Administration approved Bayer’s oral HER2‑directed drug Hyrnuo (sevabertinib) for adults with locally advanced or metastatic non‑squamous NSCLC harboring activating HER2...

Pfizer released full Phase 3 data showing its experimental mRNA influenza vaccine candidate delivered a 34.5% greater protective efficacy than a standard control vaccine in the trial cohort. The...

Novartis announced plans to build a flagship manufacturing hub across its North Carolina sites, adding new biologics, sterile packaging and solid‑dose facilities in Durham and Morrisville. The...

The FDA announced plans to add more than 1,000 staffers and launched a pilot communications program that allows sponsors to submit one brief email clarification to Office of New Drugs review staff...

Eli Lilly briefly became the first pharmaceutical company to reach a $1 trillion market capitalization, a milestone driven by blockbuster growth in its obesity and diabetes portfolio. The intraday...

Novo Nordisk and Eli Lilly are setting up direct contracting channels with self‑insured employers to offer high‑cost obesity medications, bypassing some traditional distribution and PBM pathways....

The Centers for Disease Control and Prevention quietly revised language on a vaccine safety web page to state that the claim 'vaccines do not cause autism' cannot be ruled as evidence‑based, a...

France‑based Ocean Diagnostics reported that a one‑year pilot study at Bordeaux University Hospital showed its rapid sepsis identification test matched all bloodstream infections detected by...

Tel Aviv‑based Cassidy Bio closed an $8 million seed round led by Ahren Innovation Capital to develop an AI platform that predicts optimal combinations of guide RNAs, editing enzymes and delivery...

Abbott announced a definitive agreement to acquire Exact Sciences for approximately $21 billion in cash, expanding Abbott’s diagnostics footprint into cancer screening and precision oncology....

The FDA granted accelerated approval to Bayer’s oral HER2-directed therapy Hyrnuo (sevabertinib) for adults with locally advanced or metastatic non-small-cell lung cancer bearing activating HER2...

Function Health raised $298 million in a Series B led by Redpoint Ventures, valuing the lab-testing startup at roughly $2.5 billion. The company sells subscription-based access to over 160 lab...

Tessera Therapeutics confirmed it will begin the first human trial of its in vivo gene‑writing platform, testing an approach intended to install permanent genetic changes without double-strand...

Contineum Therapeutics reported topline results from its Phase 2 VISTA trial of PIPE‑307, an M1 receptor antagonist developed in partnership with Johnson & Johnson, and the study missed its...

AnaptysBio filed a verified complaint in Delaware Chancery Court claiming Tesaro (a GSK subsidiary) materially breached a 2014 collaboration and exclusive license agreement related to Jemperli and...